Growth Metrics

Scholar Rock Holding (SRRK) Change in Account Payables (2017 - 2026)

Scholar Rock Holding's quarterly Change in Account Payables came in at -$1.1 million in Q1 2026, up 80.82% year-on-year from -$600032.3 in Q1 2025, and down 130.66% quarter-over-quarter from $3.5 million in Q4 2025.

Scholar Rock Holding has reported Change in Account Payables for 10 years, with the latest figure at -$1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables rose 80.82% year-over-year to -$1.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 202.21% YoY), and the FY2025 full-year result was $208000.0, down 96.86% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$1.1 million, down from $3.5 million in the prior quarter.
  • The five-year high for Change in Account Payables was $6.0 million in Q4 2024, with the low at -$5.7 million in Q1 2025.
  • Average Change in Account Payables over 5 years is $292529.4, with a median of -$274000.0 recorded in 2023.
  • Peak annual rise in Change in Account Payables reached 648.68% in 2025, while the deepest fall reached 827.54% in 2025.
  • Tracing SRRK's Change in Account Payables over 5 years: stood at $2.0 million in 2022, then declined by 24.92% to $1.5 million in 2023, then soared by 302.4% to $6.0 million in 2024, then tumbled by 41.25% to $3.5 million in 2025, then slumped by 130.66% to -$1.1 million in 2026.
  • The last three Change in Account Payables figures came in at -$1.1 million (Q1 2026), $3.5 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -3.26 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 35.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - -1.09 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.09 Mn
Mar 31, 2026 -1.09 Mn
Dec 31, 2025 3.54 Mn
Dec 31, 2025 3.54 Mn
Sep 30, 2025 5.66 Mn
Sep 30, 2025 5.66 Mn
Jun 30, 2025 -3.33 Mn
Jun 30, 2025 -3.33 Mn
Mar 31, 2025 -5.66 Mn
Mar 31, 2025 -5.66 Mn
Dec 31, 2024 6.02 Mn
Dec 31, 2024 6.02 Mn
Sep 30, 2024 756,000.00
Sep 30, 2024 756,000.00
Jun 30, 2024 460,000.00
Jun 30, 2024 460,000.00
Mar 31, 2024 -610,000.00
Mar 31, 2024 -610,000.00
Dec 31, 2023 1.50 Mn
Dec 31, 2023 1.50 Mn
Sep 30, 2023 -1.08 Mn
Sep 30, 2023 -1.08 Mn
Jun 30, 2023 -676,000.00
Jun 30, 2023 -676,000.00
Mar 31, 2023 -274,000.00
Mar 31, 2023 -274,000.00
Dec 31, 2022 1.99 Mn
Dec 31, 2022 1.99 Mn
Sep 30, 2022 -851,000.00
Sep 30, 2022 -851,000.00
Jun 30, 2022 186,000.00
Jun 30, 2022 186,000.00
Mar 31, 2022 -1.58 Mn
Mar 31, 2022 -1.58 Mn
Dec 31, 2021 2.21 Mn
Dec 31, 2021 2.21 Mn
Sep 30, 2021 585,000.00
Sep 30, 2021 585,000.00
Jun 30, 2021 -551,000.00
Jun 30, 2021 -551,000.00
Mar 31, 2021 -1.23 Mn
Mar 31, 2021 -1.23 Mn
Dec 31, 2020 2.13 Mn
Dec 31, 2020 2.13 Mn
Sep 30, 2020 -1.57 Mn
Sep 30, 2020 -1.57 Mn
Jun 30, 2020 454,000.00
Jun 30, 2020 454,000.00
Mar 31, 2020 1.09 Mn
Mar 31, 2020 1.09 Mn
Dec 31, 2019 -678,000.00
Dec 31, 2019 -678,000.00
Sep 30, 2019 364,000.00
Sep 30, 2019 364,000.00
Jun 30, 2019 -930,000.00
Jun 30, 2019 -930,000.00
Mar 31, 2019 -98,000.00
Mar 31, 2019 -98,000.00
Dec 31, 2018 1.37 Mn
Dec 31, 2018 1.37 Mn
Sep 30, 2018 -170,000.00
Sep 30, 2018 -170,000.00
Jun 30, 2018 -1.07 Mn
Jun 30, 2018 -1.07 Mn
Mar 31, 2018 1.53 Mn
Mar 31, 2018 1.53 Mn
Dec 31, 2017 -1.02 Mn
Dec 31, 2017 -1.02 Mn
Sep 30, 2017 1.02 Mn
Sep 30, 2017 1.02 Mn